japan-korea-taiwan gyn conferece mini lecture
TRANSCRIPT
![Page 1: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/1.jpg)
Yoshiki Mikami, M.D., Ph.D.
Department of Diagnostic PathologyKumamoto University Hospital
Seromucinous Tumor
Japan-Korea-Taiwan GYN ConfereceMini Lecture
![Page 2: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/2.jpg)
![Page 3: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/3.jpg)
3
Mucinous tumorsIntestinal Benign
Borderline
Malignant
Endocervical-like Borderline
WHO2003
Mucinous tumorsBenign
Borderline
Malignant
Seromucinoustumors
Benign
Borderline
Malignant
WHO2014
![Page 4: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/4.jpg)
Overview
•General understanding
•Controversies
–Discussion
4
![Page 5: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/5.jpg)
Seromucinous borderline tumor
5
• Unilocular oroligolocular
• Granular or papillaryexcrescences
• Viscid and/orpurulent material
• Frequently bilateral(40%) and a/wendometriosis (50%)
![Page 6: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/6.jpg)
Seromucinous borderline tumor
6
• Microscopicfeatures
Architecturallyresembling SBT
Wide papillaeshowing hierarchicalbranching
![Page 7: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/7.jpg)
7
![Page 8: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/8.jpg)
Seromucinous borderline tumor
8
• Microscopicfeatures
Cytology• Mucinous cells• Ciliated cells
![Page 9: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/9.jpg)
Seromucinous borderline tumor
9
• Microscopicfeatures
Cytology• Mucinous cells• Ciliated cells
![Page 10: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/10.jpg)
Seromucinous borderline tumor
10
• Microscopicfeatures
Cytology• Mucinous cells• Ciliated cells• Indifferent cells
![Page 11: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/11.jpg)
Implants11
![Page 12: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/12.jpg)
Implants12
![Page 13: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/13.jpg)
Implants13
![Page 14: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/14.jpg)
14Implants(desmoplastic)
![Page 15: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/15.jpg)
15Implants(desmoplastic)
![Page 16: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/16.jpg)
Seromucinouscystadenoma / adenofibroma
16
![Page 17: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/17.jpg)
17
![Page 18: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/18.jpg)
18
![Page 19: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/19.jpg)
19
![Page 20: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/20.jpg)
20
![Page 21: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/21.jpg)
21
![Page 22: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/22.jpg)
22
Seromucinous borderline tumorwith intraepithelial carcinoma
![Page 23: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/23.jpg)
23
![Page 24: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/24.jpg)
Seromucinous carcinoma
24
![Page 25: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/25.jpg)
25
![Page 26: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/26.jpg)
26
![Page 27: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/27.jpg)
27
![Page 28: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/28.jpg)
28
![Page 29: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/29.jpg)
Overview
•General understanding
•Controversies
–Discussion
29
![Page 30: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/30.jpg)
30Normal endocervical glands
![Page 31: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/31.jpg)
31Normal endocervical glands
![Page 32: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/32.jpg)
32SeromucinousNormal
Endocervical gland
![Page 33: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/33.jpg)
• Ovarian tumors of low malignantpotential exhibiting an epithelialproliferation of mucinous type cellsgreater than seen in their benigncounterparts but without destructivestromal invasion
• The mucinous epithelial cells resembleendocervical epithelium
Endocervical-like mucinousborderline tumor
WHO2003
![Page 34: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/34.jpg)
• Non-invasive proliferative tumorcomposed of more than one typesof epithelial cells
• Predominantly serous andendocervical types
• Occasionally admixed withendometrioid, clear cell, andsquamous epithelium
Seromucinous borderline tumor
WHO2014
![Page 35: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/35.jpg)
35
![Page 36: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/36.jpg)
36
![Page 37: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/37.jpg)
37
![Page 38: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/38.jpg)
38
![Page 39: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/39.jpg)
Seromucinous borderline tumor
WHO2014
Synonyms
• Endocervical-like MBT• Müllerian MBT• Borderline müllerian tumor
![Page 40: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/40.jpg)
Seromucinous borderline tumor
WHO2014
Name Morphology Definition
“Seromucinous” Endocervical Mixed müllerian
![Page 41: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/41.jpg)
41
![Page 42: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/42.jpg)
42
![Page 43: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/43.jpg)
43
![Page 44: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/44.jpg)
44
Seromucinous borderline tumor
![Page 45: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/45.jpg)
45
Seromucinous borderline tumor
Endocervical type
Serous typeEndometrioid typeClear cell typeSquamous type(Transitional type)
! No strict quantitative criteria
![Page 46: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/46.jpg)
46
Seromucinous borderline tumor
! No strict quantitative criteria
Seromucinous ????
Serous typeEndometrioid typeClear cell typeSquamous type(Transitional type)
Endocervical type
![Page 47: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/47.jpg)
Seromucinous borderline tumor
47
KRAS mutation(Kim KR et al,2010)
Similar toendometrioidtumors
![Page 48: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/48.jpg)
Seromucinous borderline tumor
48
ER/PR+WT1-CK20-、CDX2-ARID1A mutation(Kurman et al. 2016)
Similar toendometrioid orclear cell tumors
![Page 49: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/49.jpg)
49
Seromucinous Tumors of the OvaryWhat’s in a Name ?
Kurman RJ and Shih I-M. Int J Gynecol Pathol 2016; 35: 78-81
… Based on their clinicopathologic,immunohistochemical and molecular geneticfeatures we believe a more appropriatedesignation for this group of tumors is "mixedmüllerian tumors" which can be subcategorized as"mixed müllerian cystadenomas", "mixed müllerianatypical proliferative (borderline) tumors" and"mixed müllerian carcinomas".
![Page 50: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/50.jpg)
Seromucinous carcinoma
50
Vs Endometrioid carcinoma withmucinous differentiation
![Page 51: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/51.jpg)
51
![Page 52: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/52.jpg)
52
Seromucinous carcinoma Endometrioid carcinomawith mucinousdifferentiation
Background Seromucinous borderline tumor Prototypical endometrioidcarcinoma
![Page 53: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/53.jpg)
53Rambau PF, et al. Am J Surg Pathol. 2017;41: 685-695.
• Seromucinous carcinomamay be reclassified toendometrioid, low-gradeserous, and mucinouscarcinomas by integratingmorphology,immunophenotype, andgenotype.
• the category ofseromucinous carcinomabe discontinued asancillary molecular testscan assign cases to oneof the major histotypes
![Page 54: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/54.jpg)
54Rambau PF, et al. Am J Surg Pathol. 2017;41: 685-695.
• Seromucinous carcinomamay be reclassified toendometrioid, low-gradeserous, and mucinouscarcinomas by integratingmorphology,immunophenotype, andgenotype.
• the category ofseromucinous carcinomabe discontinued asancillary molecular testscan assign cases to oneof the major histotypes
![Page 55: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/55.jpg)
55Rambau PF, et al. Am J Surg Pathol. 2017;41: 685-695.
• Seromucinous carcinomamay be reclassified toendometrioid, low-gradeserous, and mucinouscarcinomas by integratingmorphology,immunophenotype, andgenotype.
• the category ofseromucinous carcinomabe discontinued asancillary molecular testscan assign cases to oneof the major histotypes
LG-ndometrioid
LG Serous
Mucinous
"SEROMUCINOUSCARCINOMA"
8/32 (25%)
23/32 (72%)
1/32 (3%)
![Page 56: Japan-Korea-Taiwan GYN Conferece Mini Lecture](https://reader036.vdocument.in/reader036/viewer/2022070503/62c0fec8cc729836455014f3/html5/thumbnails/56.jpg)
Do you like it ?
TAKE HOME